drugset / Trial / NCT02849353
Combination of Cryosurgey and NK Immunotherapy for Recurrent Ovarian Cancer
Phase 1/2
Completed
30 enrolled
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of this study is the safety and efficacy of cryosurgery plus NK immunotherapy to recurrent ovarian cancer.
Timeline
- Start
- 2016-07-01
- Primary completion
- 2017-07-01
- Completion
- 2019-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | natural killer (NK) cells | Cell therapy | 8e+09 cells | Intravenous |
| Subject | natural killer (NK) cells | Cell therapy | 1e+10 cells | Intravenous |